Back to Search Start Over

MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML

Authors :
Naidu M. Vegi
Josef Klappacher
Franz Oswald
Medhanie A. Mulaw
Amit Mandoli
Verena N. Thiel
Shiva Bamezai
Kristin Feder
Joost H.A. Martens
Vijay P.S. Rawat
Tamoghna Mandal
Leticia Quintanilla-Martinez
Karsten Spiekermann
Wolfgang Hiddemann
Konstanze Döhner
Hartmut Döhner
Hendrik G. Stunnenberg
Michaela Feuring-Buske
Christian Buske
Source :
Cell Reports, Vol 16, Iss 2, Pp 498-507 (2016)
Publication Year :
2016
Publisher :
Elsevier, 2016.

Abstract

Homeobox genes are known to be key factors in leukemogenesis. Although the TALE family homeodomain factor Meis1 has been linked to malignancy, a role for MEIS2 is less clear. Here, we demonstrate that MEIS2 is expressed at high levels in patients with AML1-ETO-positive acute myeloid leukemia and that growth of AML1-ETO-positive leukemia depends on MEIS2 expression. In mice, MEIS2 collaborates with AML1-ETO to induce acute myeloid leukemia. MEIS2 binds strongly to the Runt domain of AML1-ETO, indicating a direct interaction between these transcription factors. High expression of MEIS2 impairs repressive DNA binding of AML1-ETO, inducing increased expression of genes such as the druggable proto-oncogene YES1. Collectively, these data describe a pivotal role for MEIS2 in AML1-ETO-induced leukemia.

Subjects

Subjects :
Biology (General)
QH301-705.5

Details

Language :
English
ISSN :
22111247
Volume :
16
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Cell Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.568dc4d735944c92a3a29ec0ac42945f
Document Type :
article
Full Text :
https://doi.org/10.1016/j.celrep.2016.05.094